{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:51:44Z","timestamp":1780422704175,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.drugalcdep.2014.11.016","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T21:42:01Z","timestamp":1417038121000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers"],"prefix":"10.1016","volume":"146","author":[{"given":"Eric A.","family":"Woodcock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie H.","family":"Lundahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0376-8716(97)00049-5","article-title":"A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence","volume":"46","author":"Alterman","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0010","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0024-3205(94)00848-5","article-title":"Alternate-day dosing during buprenorphine treatment of opioid dependence","volume":"54","author":"Amass","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/105504901750227778","article-title":"Gradual dose taper following chronic buprenorphine","volume":"10","author":"Becker","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2004.06.007","article-title":"Utility of lead-in period in cocaine dependence pharmacotherapy trials","volume":"77","author":"Bisaga","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/146598901300271103","article-title":"A pilot study of the effectiveness of buprenorphine and methadone as detoxication agents when choice is given to the consumer","volume":"6","author":"Cameron","year":"2001","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archpsyc.1992.01820060044007","article-title":"Contrast of treatment-seeking and untreated cocaine abusers","volume":"49","author":"Carroll","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0035","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(01)00445-6","article-title":"Mechanisms of opioid-induced pain and antinociceptive tolerance: signal transduction","volume":"95","author":"Colpaert","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","article-title":"The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review","volume":"119","author":"Dunn","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00137-X","article-title":"Results of a baseline urine test predict levels of cocaine use during treatment","volume":"62","author":"Ehrman","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/BF03203630","article-title":"GPOWER: a general power analysis program","volume":"28","author":"Erdfelder","year":"1996","journal-title":"Behav. Res. Methods Instrum. Comput."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0070","series-title":"Structured Clinical Interview for DSM-IVAxis I Disorders* Research Version, SCID-I, V. 2.0","author":"First","year":"1996"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1901\/jaba.2008.41-603","article-title":"Opioid abstinence reinforcement delays heroin lapse during buprenorphine dose tapering","volume":"41","author":"Greenwald","year":"2008","journal-title":"J. Appl. Behav. Anal."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2010.03.020","article-title":"Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin-dependent volunteers","volume":"111","author":"Greenwald","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"(Epub Aug 19) Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00213-012-2868-9","article-title":"Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals","volume":"225","author":"Greenwald","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2009.04.006","article-title":"Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply","volume":"104","author":"Greenwald","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jsat.2012.08.016","article-title":"Predictors of outcome after short-term stabilization with buprenorphine","volume":"44","author":"Hillhouse","year":"2013","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index. Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","volume":"108","author":"Meader","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: a controlled clinical trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drugalcdep.2011.11.005","article-title":"Motivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals","volume":"123","author":"Papke","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1208\/aapsj070360","article-title":"Mu opioid receptor regulation and opiate responsiveness","volume":"7","author":"Raehal","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0160","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archpsyc.1985.01790340050008","article-title":"Untreated opiate addicts. How do they differ from those seeking treatment?","volume":"42","author":"Rounsaville","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0165","unstructured":"SAMHSA, 2012. Results from the 2011 National Survey on Drug Use And Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/1064-1297.3.4.424","article-title":"Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers","volume":"3","author":"Schuster","year":"1995","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.addbeh.2008.11.017","article-title":"Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study","volume":"34","author":"Sigmon","year":"2009","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0180","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamapsychiatry.2013.2216","article-title":"A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","volume":"70","author":"Sigmon","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0185","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1523\/JNEUROSCI.20-12-04555.2000","article-title":"Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain","volume":"20","author":"Sim-Selley","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0195","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaac.2011.07.010","article-title":"Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-4603(80)90007-6","article-title":"Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines","volume":"5","author":"Stitzer","year":"1980","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0205","unstructured":"UNODC, 2013. World Drug Report 2013. United Nations, New York, E.13.XI.6."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0210","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0215","series-title":"Structural Equation Modeling: Concepts, Issues, and Applications","first-page":"56","article-title":"Structural equation models with nonnormal variables: problems and remedies","author":"West","year":"1995"},{"key":"10.1016\/j.drugalcdep.2014.11.016_bib0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614019280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614019280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T21:43:43Z","timestamp":1566078223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614019280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":44,"alternative-id":["S0376871614019280"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}